KLF11 Polyclonal Antibody

KLF11 Polyclonal Antibody

The KLF11 polyclonal antibody is a highly specific and sensitive tool for the detection and quantification of KLF11 protein in various biological samples. KLF11, also known as TIEG2, is a transcription factor that plays a critical role in the regulation of cell growth, differentiation, and apoptosis. Dysregulation of KLF11 expression has been implicated in the pathogenesis of several diseases, including diabetes, cancer, and cardiovascular disorders.

The KLF11 polyclonal antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the KLF11 protein. The resulting antibody is purified using a combination of protein A and protein G chromatography to ensure high specificity and low background binding. The antibody has been validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The KLF11 polyclonal antibody has several advantages over other commercially available antibodies. Firstly, it has been extensively characterized and validated for its specificity and sensitivity, ensuring accurate and reliable results. Secondly, it is highly versatile and can be used in a wide range of applications, making it a valuable tool for researchers studying KLF11 function and regulation. Finally, it is available in a range of formats and sizes, allowing researchers to choose the best option for their specific needs.

In summary, the KLF11 polyclonal antibody is a high-quality reagent that offers researchers a reliable and versatile tool for the detection and quantification of KLF11 protein in various biological samples. Its high specificity, sensitivity, and versatility make it an essential tool for researchers studying the role of KLF11 in health and disease.